Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Breast Neoplasms 41Carcinoma, Renal Cell 32Neuroendocrine Tumors 15Neoplasms 12Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 8Carcinoma 7Tuberous Sclerosis 6Kidney Neoplasms 5Carcinoma, Hepatocellular 5Carcinoid Tumor 5Lymphoma 4Adenoma, Islet Cell 4Stomach Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Lymphangioleiomyomatosis 3Lung Neoplasms 3Colorectal Neoplasms 3Angiomyolipoma 3Adenocarcinoma 3von Hippel-Lindau Disease 2Triple Negative Breast Neoplasms 2Seizures 2Neuroectodermal Tumors, Primitive 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2

Interventions

Carboplatin 3motexafin gadolinium 2figitumumab 2cemiplimab 2brigatinib 2alpha-2'-deoxythioguanosine 2Paclitaxel 2Docetaxel 2vandetanib 1tanespimycin 1Vinorelbine 1Temozolomide 1Pemetrexed 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Crizotinib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Large Cell × Everolimus × Clear all
NCT01317615 2016-03-30

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

Novartis

Phase 4 Completed
49 enrolled 11 charts
EndocrineNETThoracic

Lung Neoplasms, Carcinoma, Large Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡